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Abstract
Background: Atherogenic lipoprotein profile of plasma is an important risk factor for
atherosclerosis. The atherogenic index of plasma (AIP) has been suggested as a novel
marker for atherosclerosis.
Hypothesis: AIP is a useful marker of advanced subclinical coronary artery disease
(CAD) in subjects without overt renal dysfunction.
Methods: A total of 6928 subjects with estimated glomerular filtration rate > 60 mL/
minutes/1.73 m2 evaluated by coronary computed tomography angiography (CCTA)
for health check-up were included. The relation of AIP to advanced CAD (heavy coro-
nary calcification, defined as coronary artery calcium score [CACS] >100 or obstruc-
tive coronary plaque [OCP], defined as plaque with >50% stenosis) was evaluated.
Results: All participants were stratified into four groups based on AIP quartiles. The
prevalence of CACS >100 (group I [lowest] 4.7% vs group II 7.0% vs group III 8.8% vs
group IV 10.0%) and OCP (group I 3.7% vs group II 6.4% vs group III 8.8% vs group
IV 10.9%) (all P < .001) increased with elevating AIP quartiles. Higher AIP (per 0.1 unit
increase) was associated with an increased risk of CACS >100 (odds ratio [OR] 1.057,
95% confidence interval (CI) 1.010 to 1.106, P = .017; relative risk (RR) 1.048, 95% CI
1.009-1.089, and P = .015) and OCP (OR 1.079, 95% CI 1.033-1.127, P = .001; RR
1.069, 95% CI 1.031-1.108, P < .001) after adjusting for age > 60 years, male sex,
hypertension, diabetes mellitus, dyslipidaemia, obesity, and proteinuria.
Conclusion: AIP is independently associated with advanced subclinical CAD beyond
traditional risk factors.
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1 | INTRODUCTION
Atherogenic lipoprotein profile of plasma is an important risk factor
for atherosclerosis. The atherogenic index of plasma (AIP) has been
suggested as a marker of plasma atherogenicity based on its strong
and positive association with cholesterol esterification rates, lipopro-
tein particle size, and remnant lipoproteinaemia.1-3 In addition, previ-
ous data have shown that AIP is more closely related to
cardiovascular (CV) risk than individual lipoprotein cholesterol frac-
tions or other atherogenic indices.4-6 However, data on the associa-
tion of AIP with the advanced subclinical coronary artery disease
(CAD) beyond traditional risk factors are limited in clinical practice.
Coronary artery calcium score (CACS) has been regarded as a use-
ful marker of coronary atherosclerosis because it represents the
degree of atheromatous plaque burden.7,8 Recently, coronary com-
puted tomography angiography (CCTA) has been used as an effective
and noninvasive tool to assess the presence of plaques, severity of
stenosis, and subtypes of plaque in coronary arteries with a robust
ability to predict major adverse CV events.9-11 Thus, this study evalu-
ated the association of AIP with advanced subclinical CAD in subjects
without overt renal dysfunction using CCTA.
2 | METHODS
2.1 | Study population and design
This observational, retrospective, single-center registry consisted of
8648 consecutive participants evaluated by CCTA for health check-up
with 64-slice multidetector computed tomography between January
2004 and April 2009 at Severance CV hospital.12 Of them, 1720 sub-
jects were excluded because of (a) age < 30 years (n = 69), (b) overt
renal dysfunction defined as glomerular filtration rate (GFR) estimated
by modification of diet in renal disease (MDRD) method <60 mL/
minutes/1.73 m2 (n = 958), and (c) insufficient medical records for tradi-
tional risk factor and AIP calculation or poor image quality (n = 693). As
a result, 6928 participants were finally included in the present study.
The study protocol was approved by the ethics committee of severance
CV Hospital, and informed consent for the procedure was obtained
from each participant. Patients or the public were not involved in the
design, conduct, reporting, or dissemination of our research.
Medical history of hypertension, diabetes mellitus, and
dyslipidaemia was systematically acquired. Height, body weight, and
blood pressure (BP) were measured during visits. Height and weight
measurements were obtained while the subjects wore light clothing
without shoes. Body mass index (BMI) was calculated as weight in
kilograms divided by the square of height in meters. After the partici-
pants rested for ≥5 minutes, the BP was measured at the right arm
using an automatic manometer with an appropriate cuff size. Serum
levels of total cholesterol, triglycerides, high-density lipoprotein cho-
lesterol (HDL-C), low-density lipoprotein cholesterol (LDL-C), glucose,
and creatinine were measured after a minimum of 12 hours fasting
period. The AIP was calculated as the base 10 logarithm of the ratio
of the triglycerides to HDL-C concentrations.1 The kidney function
was ascertained by estimated GFR calculated using the MDRD for-
mula.13 Hypertension was defined as systolic BP ≥140 mmHg and/or
diastolic BP ≥90 mmHg or treatment with antihypertensive agents.
Diabetes mellitus was defined as treatment with hypoglycaemic
agents or insulin, or fasting glucose ≥126 mg/dL. Dyslipidaemia was
defined as serum levels of total cholesterol ≥240 mg/dL, LDL-
C ≥ 130 mg/dL, HDL-C ≤ 40 mg/dL, triglycerides ≥150 mg/dL, and/or
treatment with lipid lowering agents. Obesity was defined as BMI
≥25 kg/m2 based on the cutoffs for Asian population. Proteinuria was
defined based on the sex-specific urinary albumin/creatinine
ratio.14,15 Age ≥ 60 years, male sex, hypertension, diabetes mellitus,
dyslipidaemia, obesity, and proteinuria were considered as traditional
risk factors in the present study. All procedures were in accordance
with the ethical standards of the institutional research committee
(Giessen, AZ.: 127/16) and with the 1964 Helsinki declaration and its
later amendments or comparable ethical standards.
2.2 | CCTA protocol
During CCTA examination, subjects with an initial heart rate > 65
beats/minutes received a single oral dose of 50 mg metoprolol tar-
trate (Betaloc, Yuhan, Seoul, Korea) 1 to 2 hours before the examina-
tion if beta blocking agents were not contraindicated. A 64-slice
scanner (Sensation 64; Siemens Medical Systems, Forchheim, Ger-
many) was used for examination. First, a nonenhanced prospective
electrocardiogram (ECG)-gated scan was obtained for the measure-
ment of CACS with the following parameters: rotation time of
330 ms, slice width of 3.0 mm, slice collimation of 0.6 mm, tube cur-
rent of 50 mA, tube voltage of 120 kV, and table feed/scan of
18 mm. Subsequently, CCTA was performed using retrospective
ECG gating with the following scan parameters: rotation time of
330 ms, slice collimation of 64 × 0.6 mm, tube voltage of 100 to
120 kV, tube current of 600 to 800 mA depending on patient size,
table feed/scan of 3.8 mm, and pitch factor of 0.2. ECG-based tube
current modulation was applied to 65% of the R-R interval. A real-
time bolus-tracking technique was used to trigger the initiation of
the scan. The total estimated average radiation dose for the
multislice protocol was 10.9 ± 1.9 mSv. Contrast enhancement was
achieved with 60 mL iopamidol (370 mg iodine/mL, Iopamiro;
Bracco, Milan, Italy) injected at 5 mL/s, followed by an injection of
30 mL diluted contrast, and then 30 mL saline at 5 mL/s using an
injector (Envision CT; Medrad, Indianola, Pennsylvania). The images
were evaluated by two experienced cardiac radiologists. CACS,
which was measured using the scoring system described by Agatston
et al,16 was categorized into four groups based on the following
scores: 0, 1 to 10, 11 to 100, and >100. Coronary plaques were
defined as structures ≥1 mm2 within or adjacent to the vessel lumen,
which were clearly distinguishable from the lumen and the surround-
ing pericardial tissue. Plaques without calcium were classified as
noncalcified, those with calcified tissue involving ≥50% of the plaque
area (density > 130 HU) were classified as calcified, and those with
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<50% calcium were classified as mixed plaques.17 Two outcome vari-
ables were selected for identifying the advanced CAD: (a) CACS
>100 and (b) obstructive coronary plaque (OCP) defined as coronary
plaque with ≥50% luminal narrowing. Representative CCTA images
are presented in Figure 1.
2.3 | Statistical analysis
Continuous variables were expressed as mean ± SD. Categorical vari-
ables were presented as absolute values and proportions. To compare
the characteristics among the AIP quartiles, one-way analysis of variance
F IGURE 1 Representative CCTA
images. CCTA, coronary computed
tomography angiography




(n = 1764) −0.60 − 0.14
II (n = 1792)
0.15-0.35
III (n = 1690)
0.36-0.55
IV (highest)
(n = 1682) 0.56-1.79
Age, years 50.3 ± 9.4 52.9 ± 9.7 53.1 ± 9.8 51.9 ± 9.5 <.001
Male, n (%) 628 (35.6) 979 (54.6) 1123 (66.4) 1247 (74.1) <.001
Systolic BP, mmHg 124.8 ± 14.6 125.8 ± 14.6 127.0 ± 14.2 127.4 ± 15.2 .012
Diastolic BP, mmHg 78.2 ± 9.3 78.2 ± 9.4 79.3 ± 9.7 79.8 ± 9.7 .004
BMI, kg/m2 22.7 ± 2.8 24.0 ± 2.8 24.8 ± 2.7 25.4 ± 2.7 <.001
Hypertension, n (%) 340 (19.3) 507 (28.3) 570 (33.7) 579 (34.4) <.001
Diabetes mellitus, n (%) 109 (6.2) 184 (10.3) 208 (12.3) 275 (16.3) <.001
Dyslipidemia, n (%) 326 (18.5) 637 (35.5) 1084 (64.1) 1681 (99.9) <.001
Obesity, n (%) 321 (18.2) 623 (34.8) 756 (44.7) 931 (55.4) <.001
Total cholesterol, mg/dL 191.8 ± 33.0 195.7 ± 36.4 198.8 ± 35.9 200.3 ± 36.8 <.001
Triglyceride, mg/dL 64.8 ± 15.6 99.4 ± 19.6 140.1 ± 27.1 241.3 ± 111.6 <.001
HDL-C, mg/dL 66.2 ± 12.5 55.1 ± 9.5 49.3 ± 8.3 42.7 ± 7.6 <.001
LDL-C, mg/dL 104.7 ± 28.0 115.8 ± 30.0 120.9 ± 30.9 113.7 ± 30.1 <.001
Glucose, mg/dL 97.4 ± 17.2 100.1 ± 22.2 102.3 ± 22.7 107.5 ± 32.2 <.001
Creatinine, mg/dL 0.94 ± 0.16 0.98 ± 0.17 1.00 ± 0.17 1.02 ± 0.17 <.001
GFR, mL/min/1.73 m2 76.4 ± 11.3 77.1 ± 11.8 77.5 ± 11.1 78.2 ± 11.3 <.001
Albumin creatinine ratio 10.0 ± 22.4 10.0 ± 17.2 14.2 ± 62.6 25.3 ± 128.4 <.001
Proteinuria, n (%) 90 (5.5) 109 (6.6) 106 (6.7) 152 (9.8) <.001
Note: Values are presented as the mean ± SD or number (%).
Abbreviations: AIP, atherogenic index of plasma; BMI, body mass index; BP, blood pressure; HDL-C, high-density lipoprotein cholesterol; LDL-C, low-
density lipoprotein cholesterol.
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was used for continuous variables, and the χ2-test or Fisher's exact test
was used for categorical variables, as appropriate. Univariate logistic
regression analysis was performed to identify the association between
clinical variables and coronary atherosclerotic parameters. Multiple logis-
tic regression analysis was used to identify the predictive value of AIP
for advanced CAD. The forced entry method was used to enter indepen-
dent variables into the multivariate regression analysis model. Receiver
operating characteristic (ROC) curve analysis with Youden index was
conducted to determine an optimal cutoff of AIP for predicting advanced
CAD. We then compared the predictive significance of the optimal AIP
cutoff for advanced CAD after considering traditional risk factors. All sta-
tistical analyses were performed with the Statistical Package for the
Social Sciences version 19 (IBM Corp., Armonk, New York) and SAS ver-
sion 9.1.3 (SAS Institute Inc., Cary, North Carolina). A P-value <.05 was
considered significant for all analyses.
3 | RESULTS
3.1 | Baseline characteristics
The mean age of participants was 52.0 ± 9.7 years and 3977 (57.4%)
of them were men. The prevalence of hypertension, diabetes mellitus,
dyslipidaemia, obesity, and proteinuria was 28.8%, 11.2%, 53.8%,
38.0%, and 6.6%, respectively. The CACS >100 and OCP was
observed in 7.6% and 7.4% of subjects, respectively. All participants
were categorized into four-groups based on the AIP quartiles. The
ranges of the AIP in stratified groups of I (lowest), II, III, and IV
(highest) were 0.60 to 0.14, 0.15 to 0.35, 0.36 to 0.55, and 0.56 to
1.79, respectively. Systolic and diastolic BP values, serum levels of
total cholesterol, triglycerides, glucose, and creatinine, albumin/creati-
nine ratio, and the prevalence of male sex, hypertension, diabetes
F IGURE 2 Comparison of CACS and OCP according to AIP
quartiles. AIP, atherogenic index of plasma; CACS, coronary artery
calcium score; CAD, coronary artery disease; OCP, obstructive
coronary plaque
TABLE 2 Association of clinical
variables with CACS >100 and
obstructive plaque
CACS >100 OCP
OR (95% CI) P OR (95% CI) P
Age, years 1.136 (1.123-1.148) <.001 1.099 (1.088-1.110) <.001
Male 2.203 (1.803-2.692) <.001 2.029 (1.662-2.478) <.001
Hypertension 2.733 (2.283-3.271) <.001 2.445 (2.038-2.932) <.001
Diabetes mellitus 3.948 (3.217-4.845) <.001 3.303 (2.672-4.083) <.001
Dyslipidemia 1.483 (1.234-1.782) <.001 1.906 (1.573-2.309) <.001
Obesity 1.331 (1.112-1.592) .002 1.387 (1.157-1.663) <.001
Proteinuria 1.756 (1.303-2.366) <.001 1.560 (1.145-2.127) .005
AIP quartiles
I 1 – 1 –
II 1.553 (1.167-2.068) .003 1.764 (1.294-2.406) <.001
III 1.990 (1.507-2.628) <.001 2.469 (1.833-3.327) <.001
IV 2.281 (1.736-2.997) <.001 3.141 (2.350-4.197) <.001
Abbreviations: AIP, atherogenic index of plasma; CACS, coronary artery calcium score; CAD, coronary
artery disease; CI, confidence interval; OCP, obstructive coronary plaque; OR, odds ratio.
WON ET AL. 1401
mellitus, dyslipidaemia, obesity, and proteinuria significantly increased
with increasing AIP quartiles. In contrast, the mean level of HDL-C
significantly decreased with increasing AIP quartiles (Table 1). The
proportion of categorical CACS and OCP according to AIP quartiles is
presented in Figure 2. The prevalence of coronary plaque sub-types
according to AIP quartiles is presented in Supplementary Figure 1.
3.2 | Clinical variables and the risk of
advanced CAD
The association of clinical variables with CACS >100 and OCP is pres-
ented in Table 2. Age, male sex, hypertension, diabetes mellitus,
dyslipidaemia, obesity, and proteinuria were significantly associated
with an increased risk of both CACS >100 and OCP. With regard to
the association between AIP and the risk of advanced CAD, the risk
of CACS >100 and OCP was significantly higher in group II, group III,
and group IV compared with that in group I, respectively.
3.3 | Predictive value of AIP for advanced CAD
In ROC curve analysis, the optimal AIP cutoff for predicting CACS
>100 and OCP were 0.28 (sensitivity 70.5%, specificity 42.6%, area
under curve (AUC) 0.581, 95% CI 0.556-0.606, P < .001) and 0.33
(sensitivity 47.9%, specificity 68.5%, AUC 0.617, 95% confidence
interval (CI) 0.593-0.641, P < .001), respectively (Supplementary
Figure 2). After considering traditional risk factors, the predictive sig-
nificance of AIP levels greater than individual optimal cutoff for CACS
>100 (AIP >0.28 vs AIP > 0.28 with traditional risk factors AUC 0.566
vs 0.813, P < .001) and OCP (AIP >0.33 vs AIP >0.33 with traditional
risk factors AUC 0.589 vs 0.762, P < .001) incrementally improved
(Supplementary Figure 3).
3.4 | Impact of AIP on the risk of advanced CAD
beyond traditional risk factors
To identify the association of AIP with the risk of CACS >100 and
OCP, consecutive adjustment of individual traditional risk factors was
performed. An increase of AIP level (per 0.1 unit) was associated with
an increased risk of CACS >100 (odds ratio [OR] 1.057, 95%
(CI) 1.010-1.106, P = .017; relative risk (RR) 1.048, 95% CI
1.009-1.089, P = .015) and OCP (OR 1.079, 95% CI 1.033-1.127,
P = .001; RR 1.069, 95% CI 1.031-1.108, P < .001) after adjusting for
traditional risk factors (Table 3). Regarding the association of individ-
ual components of AIP with the risk of CACS >100 and OCP after
adjusting for traditional risk factors, an increase of triglycerides level
was associated with an increased risk of CACS >100; however, there
was no significant association between triglycerides level and the risk
of OCP. In contrast, an increase of HDL-C level was associated with a
decreased risk of OCP, but not of CACS <100 (Supplementary
Table 1).
4 | DISCUSSION
In the present study, a significant association was observed between
AIP and the risk of advanced subclinical CAD in subjects beyond tradi-
tional risk factors. Recently, CCTA has been widely used for the com-
prehensive evaluation of coronary atherosclerosis, including lesion
location, severity, and plaque characteristics in clinical practice.18 The
CONFIRM (Coronary CT angiography evaluation for clinical outcomes:
An international multicenter registry) studies previously revealed that
the severity of CAD as revealed by CCTA has a strong predictive
value for adverse clinical outcomes.19,20 We considered a CACS >100
an indicator of advanced coronary artery calcification based on the
facts that (1) Nasir et al.21 reported that the frequency of a CACS
>100 in the Asian population is significantly lower than that in West-
ern populations and (2) the overall proportion of CACS >100 was
7.6% in our participants. Additionally, we defined OCP as a plaque
with ≥ 50% stenosis because 1) all participants received a CCTA
examination for health check-up and (2) the prevalence of OCP was
7.4% in this study.
High levels of the triglycerides-to-HDL-C ratio have been associ-
ated with obesity and metabolic syndrome.22,23 This might be related
to the fact that hypertriglyceridemia stimulates the activity of
cholesteryl ester transfer protein, which exchanges triglycerides from
triglyceride-rich lipoproteins for cholesteryl esters from high- and
LDLs24; triglycerides enrichment of high- and LDLs particles renders
TABLE 3 Impact of AIP (per 0.1 unit increase) on CACS >100 and OCP
CACS >100 OCP
OR (95% CI) P RR (95% CI) P OR (95% CI) P RR (95% CI) P
Model 1 1.101 (1.068-1.135) <.001 1.092 (1.064-1.122) <.001 1.147 (1.112-1.182) <.001 1.133 (1.104-1.162) <.001
Model 2 1.080 (1.044-1.118) <.001 1.068 (1.037-1.100) <.001 1.131 (1.093-1.169) <.001 1.114 (1.083-1.146) <.001
Model 3 1.057 (1.010–1.106) .017 1.048 (1.009-1.089) .015 1.079 (1.033–1.127) .001 1.069 (1.031–1.108) <.001
Note: Model 1: unadjusted, Model 2: adjusted for age > 60 years and male sex, and Model 3: adjusted for age > 60 years, male sex, hypertension, diabetes
mellitus, dyslipidaemia, obesity, and proteinuria.
Abbreviations: AIP, atherogenic index of plasma; CACS, coronary artery calcium score; CAD, coronary artery disease; CI, confidence interval; OCP, obstruc-
tive coronary plaque; OR, odds ratio; RR, relative risk.
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them better substrates for lipolysis by hepatic lipase, resulting in HDL
catabolism and elimination and the formation of more numerous,
denser LDLs particles. Previously, the very large database of lipids-4
(VLDL-4) study showed that a higher ratio of triglycerides to HDL-C
was associated with an increasingly atherogenic lipid phenotype, char-
acterized by higher remnant lipoprotein particle cholesterol along with
higher nonHDL-C and LDL-C density.3 Millán et al25 suggested the
simultaneous use of triglycerides-to-HDL-C ratio is more useful than
isolated lipid values as it more closely reflects the complex interac-
tions of lipoprotein metabolism and can better predict plasma athe-
rogenicity. Based on this strong evidence, the AIP has been suggested
as an effective marker for plasma atherogenicity.
Recently, several studies demonstrated that AIP is closely related
to the coronary atherosclerosis in specific clinical conditions.26,27
However, large sample size data on the value of AIP for advanced
subclinical CAD over traditional risk factors in general population are
limited. In this observational cohort study with cross-sectional design,
we could identify the close association of AIP with CACS >100 and
OCP in 6928 Korean adults evaluated by CCTA for health check-up.
In addition, the predictive significance of AIP for advanced subclinical
CAD improved after considering traditional risk factors together. Fur-
ther prospective longitudinal studies are necessary to confirm the role
of AIP for assessing the degree of coronary atherosclerosis in clinical
practice.
Several limitations to the study should be acknowledged. First,
this was a retrospective, cross-sectional, and observational study.
Thus, selection bias might be present. Second, potential roles of other
environmental risk factors and the diet or exercise in subclinical ath-
erosclerosis were not evaluated. Finally, this study included only the
Korean adults, which may limit the generalization of obtained results
to other populations. Despite these limitations, this study is unique in
that an independent association was identified between AIP and
advanced subclinical coronary atherosclerosis beyond traditional risk
factors in an Asian population. Furthermore, the present study investi-
gated the association of AIP with coronary plaque subtypes.
In conclusion, elevated AIP levels are significantly associated with
a higher risk of advanced subclinical CAD as revealed by CCTA in
Korean adults with near-normal renal function even after adjusting for
traditional risk factors. With consideration of traditional risk factors
together, AIP may be an effective predictive marker for advanced cor-
onary atherosclerosis in general population without overt renal
dysfunction.
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